Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott's Winning (Baby) Formula for Success. Are There More Spinoffs to Come? Comment Now Follow Comments
Forbes
Wednesday, July 17, 2013 - 12:33pm
tags:
Abbott Laboratories, spinoffs, AbbVie, nutrition, infant nutrition
Vaccine-focused Pfizer licenses out TB drug
Pharma Times, UK
Wednesday, July 17, 2013 - 11:24am
tags:
Pfizer, vaccines, tuberculosis, Sequella
How Much? Novartis Gives Vasella $25,000 A Day For Consulting
Pharmalot
Wednesday, July 17, 2013 - 11:22am
tags:
Daniel Vasella, Novartis
J&J Pays $23M To Settle Class Action Suit Over OTC Troubles
Pharmalot
Wednesday, July 17, 2013 - 11:10am
tags:
OTC, JNJ
Court finds in favor of Mylan in patent suit related to Teva's Copaxone patents
The Fly on the Wall
Wednesday, July 17, 2013 - 11:06am
tags:
Mylan, Teva Pharmaceuticals, Copaxone, patents
Will Payments To Scientists For New Drugs Improve GSK's R&D Productivity?
Forbes
Wednesday, July 17, 2013 - 11:03am
tags:
GSK, R&D
China blocks GSK finance head from leaving country
Yahoo/Reuters
Wednesday, July 17, 2013 - 11:02am
tags:
GSK, China
Ventrus Poised For Run-Up Ahead Of Phase III Results
Seeking Alpha
Wednesday, July 17, 2013 - 11:01am
tags:
Ventrus, VEN 307
3 Potential Game Changers for COPD
Motley Fool
Wednesday, July 17, 2013 - 10:59am
tags:
COPD, Anoro, GSK, Theravance, QVA149, Novartis, olodaterol, Boehringer Ingelheim, Pfizer
Ariad Pharma skids as analyst says leukemia pill Iclusig may struggle against older drugs
Yahoo/AP
Wednesday, July 17, 2013 - 10:57am
tags:
Ariad Pharmaceuticals, Iclusig, chronic myeloid leukemia
Novartis raises '13 outlook despite 2Q profit drop
Yahoo/AP
Wednesday, July 17, 2013 - 10:55am
tags:
Novartis, earnings
Abbott’s Quarterly Profit Rises on Emerging Market Sales
Bloomberg
Wednesday, July 17, 2013 - 10:54am
tags:
Abbott Laboratories, earnings
Will GlaxoSmithKline Bribery Accusations Affect the Company’s Bottom Line?
Wall St. Cheat Sheet
Tuesday, July 16, 2013 - 12:36pm
tags:
GSK, bribery, China
Merck says FDA needs more time to complete sugammadex review
Reuters
Tuesday, July 16, 2013 - 12:35pm
tags:
FDA, Merck, sugammadex
First Manhattan sues Vivus for delaying shareholder meet
Reuters
Tuesday, July 16, 2013 - 11:24am
tags:
Vivus
Alexion Takeover Would Be Priciest Since 2008: Real M&A
Bloomberg
Tuesday, July 16, 2013 - 11:21am
tags:
Alexion, Roche, M&A
Largest cancer gene database made public
Reuters
Tuesday, July 16, 2013 - 11:20am
tags:
cancer, Roche, gene database, Cisplatin, Zelboraf, Pfizer, Xalkori
Merck maintains lead in BACE inhibitors for Alzheimer's
PM Live
Tuesday, July 16, 2013 - 10:47am
tags:
Merck, Alzheimer's disease, BACE inhibitors, MK-8931
Is Big Pharma Crazy for Chasing This Deal?
Motley Fool
Tuesday, July 16, 2013 - 10:27am
tags:
Alexion, Roche, M&A
Actavis launching generic version of GlaxoSmithKline's Lamictal for epilepsy, bipolar disorder
Yahoo/AP
Tuesday, July 16, 2013 - 9:26am
tags:
GSK, Actavis, Lamictal, generics, epilepsy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.